• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Spectral AI Inc. (Amendment)

    4/19/24 6:49:51 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care
    Get the next $MDAI alert in real time by email
    SC 13G/A 1 ea0204316-13ga1hir_spe.htm AMENDMENT NO. 1 TO SCHEDULE 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

     

    SCHEDULE 13G

     

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    (Amendment No. 1)*

     

     

     

    Spectral AI, Inc.

    (Name of Issuer)

     

    Common stock, par value $0.0001 per share (“Common Stock”)

    (Title of Class of Securities)

     

    84757T105

    (CUSIP Number)

     

    March 27, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐Rule 13d-1(b)

     

    ☒Rule 13d-1(c)

     

    ☐Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    1 

    NAME OF REPORTING PERSONS

     

    Laurence E. Hirsch

    2

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a) ☐ (b) ☒

     

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States citizen

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH
    REPORTING

    PERSON

    WITH

    5 

     

    SOLE VOTING POWER

     

    900,000 Shares(1)

    6

     

    SHARED VOTING POWER 

     

    0

    7

     

    SOLE DISPOSITIVE POWER

     

    900,000 Shares(1)

    8

     

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    900,000 Shares(1)

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     ☐

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    5.15%

    12

    TYPE OF REPORTING PERSON (See Instructions)

     

    IN

     

    (1)Comprised of shares of Common Stock held by Highlander Partners, L.P., which shares were formerly held by Laurence E. Hirsch directly. Mr. Hirsch is the sole manager of Highlander Partners GP, LLC, the general partner of Highlander Partners, L.P.

     

    2

     

     

    1 

    NAME OF REPORTING PERSONS

     

    Highlander Partners, L.P.

    2

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a) ☐ (b) ☒

     

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Texas

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5 

     

    SOLE VOTING POWER

     

    900,000 Shares

    6

     

    SHARED VOTING POWER

     

    0

    7

     

    SOLE DISPOSITIVE POWER

     

    900,000 Shares

    8

     

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    900,000 Shares

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     ☐

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    5.15%

    12

    TYPE OF REPORTING PERSON (See Instructions)

     

    PN

     

    3

     

     

    1 

    NAME OF REPORTING PERSONS

     

    Highlander Partners GP, LLC

    2

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a) ☐ (b) ☒

     

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Texas

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH
    REPORTING

    PERSON

    WITH

    5 

     

    SOLE VOTING POWER

     

    0

    6

     

    SHARED VOTING POWER

     

    900,000 Shares(2)

    7

     

    SOLE DISPOSITIVE POWER

     

    0

    8

     

    SHARED DISPOSITIVE POWER

     

    900,000 Shares(2)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    900,000 Shares(2)

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     ☐

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    5.15%

    12

    TYPE OF REPORTING PERSON (See Instructions)

     

    PN

     

    (2)Comprised of shares of Common Stock held by Highlander Partners, L.P., of which Highlander Partners GP, LLC is the general partner.

     

    4

     

     

    Item 1(a). Name of Issuer

     

    Spectral AI, Inc.

     

    Item 1(b). Address of the Issuer’s Principal Executive Offices

     

    2515 McKinney Avenue, Suite 1000, Dallas, TX 75201

     

    Item 2(a). Names of Persons Filing

     

    Laurence E. Hirsch, Highlander Partners, L.P. and Highlander Partners GP, LLC

     

    Item 2(b). Address of the Principal Business Office, or if none, Residence:

     

    The address of the business office for Laurence E. Hirsch, Highlander Partners, L.P. and Highlander Partners GP, LLC is 300 Crescent Court, Suite 550, Dallas, TX 75201.

     

    Item 2(c). Citizenship

     

    Highlander Partners, L.P. and Highlander Partners GP, LLC - Texas

     

    Laurence E. Hirsch - United States citizen

     

    Item 2(d). Title of Class of Securities

     

    Common Stock, $0.0001 par value per share.

     

    Item 2(e). CUSIP Number

     

    84757T105

     

    Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

     

    ☐ (a) Broker or Dealer registered under Section 15 of the Exchange Act.
         
    ☐ (b) Bank as defined in Section 3(a)(b) or the Exchange Act.
         
    ☐ (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act.
         
    ☐ (d) Investment company registered under Section 8 of the Investment Company Act.
         
    ☐ (e) An Investment adviser in accordance with Rule 13d-1 (b)(1)(ii)(e).
         
    ☐ (f) An employee benefit plan or endowment fund in accordance with Rule 13d 1(b)(1)(ii)(f).
         
    ☐ (g) A Parent Holding Company or control person in accordance with Rule 13d 1(b)(1)(ii)(g).
         
    ☐ (h) A Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act.
         
    ☐ (i) A Church Plan that is excluded from the definition of an investment company under Section 3 (c)(14) of the Investment Company Act.
         
    ☐ (j) Group, in accordance with Rule 13d-1 (b)(1)(ii)(j).

     

    Not applicable

     

    5

     

     

    Item 4. Ownership

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a)Amount beneficially owned: **
    LaurenceE. Hirsch – 900,000 shares
    HighlanderPartners, L.P. – 900,000 shares
    HighlanderPartners GP, LLC – 900,000 shares

     

    (b)Percent of class: **
    LaurenceE. Hirsch – 5.15%
    HighlanderPartners, L.P. – 5.15%
    HighlanderPartners GP, LLC – 5.15%

     

    (c)Number of shares as to which such person has: **

     

    (i)Sole power to vote or to direct the vote:
    LaurenceE. Hirsch – 900,000 shares
    HighlanderPartners, L.P. – 900,000 shares

     

    (ii)Shared power to vote or to direct the vote:
    HighlanderPartners GP, LLC – 900,000 shares

     

    (iii)Sole power to dispose or to direct the disposition of:
    LaurenceE. Hirsch – 900,000 shares
    HighlanderPartners, L.P. – 900,000 shares

     

    (iv)Shared power to dispose or to direct the disposition of:
    HighlanderPartners GP, LLC – 900,000 shares

     

    **See footnotes on cover pages which are incorporated by reference herein. 

     

    Item 5. Ownership of Five Percent or Less of a Class

     

    Not Applicable

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person

     

    Not Applicable

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

     

    Not Applicable

     

    Item 8. Identification and Classification of Members of the Group

     

    See Exhibit B

     

    Item 9. Notice of Dissolution of Group

     

    Not Applicable

     

    Item 10. Certification

     

    “By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a–11.”

     

    6

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    DATE: April 19, 2024

     

     

      LAURENCE E. HIRSCH
         
      /s/ Nicholas Thicksten
      Name:  Nicholas Thicksten
      Title: Attorney-In-Fact
         
      HIGHLANDER PARTNERS, L.P.
         
      /s/ Chris McRorie
      Name: Chris McRorie
      Title: Vice President, General Counsel & Secretary
         
      HIGHLANDER PARTNERS GP, LLC
         
      /s/ Chris McRorie
      Name: Chris McRorie
      Title: Vice President, General Counsel & Secretary

     

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations

    (See 18 U.S.C. 1001)

     

    7

     

     

    EXHIBIT LIST

     

    Exhibit A.   Joint Filing Agreement.
    Exhibit B.   Item 8 Statement.
    Exhibit C.   Power of Attorney. (1)

     

    (1)Power of Attorney previously filed as Exhibit A to a Schedule 13G with regard to Spectral AI, Inc. filed with the Securities and Exchange Commission on November 3, 2023 by Laurence E. Hirsch.

     

    8

     

     

    Exhibit A

     

    JOINT FILING AGREEMENT

     

    The undersigned agree that this Schedule 13G, and all amendments thereto, relating to the Class A common stock of Spectral AI, Inc. shall be filed on behalf of the undersigned.

     

      LAURENCE E. HIRSCH
         
      /s/ Nicholas Thicksten
      Name:  Nicholas Thicksten
      Title: Attorney-In-Fact
         
      HIGHLANDER PARTNERS, L.P.
         
      /s/ Chris McRorie
      Name: Chris McRorie
      Title: Vice President, General Counsel & Secretary
         
      HIGHLANDER PARTNERS GP, LLC
         
      /s/ Chris McRorie
      Name: Chris McRorie
      Title: Vice President, General Counsel & Secretary

     

     

     

     

    Exhibit B

     

    Due to the relationships between them, the reporting persons hereunder may be deemed to constitute a “group” with one another for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934.

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Get the next $MDAI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MDAI

    DatePrice TargetRatingAnalyst
    1/23/2024$4.00Buy
    BTIG Research
    More analyst ratings

    $MDAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dimaio John Michael was granted 17,500 shares, increasing direct ownership by 0.66% to 2,687,847 units (SEC Form 4)

    4 - Spectral AI, Inc. (0001833498) (Issuer)

    6/1/26 4:00:40 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Director Dimaio John Michael was granted 32,233 shares, increasing direct ownership by 1% to 2,670,347 units (SEC Form 4)

    4 - Spectral AI, Inc. (0001833498) (Issuer)

    5/27/26 5:16:36 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Director Sadagopan Deepak was granted 25,000 shares (SEC Form 4)

    4 - Spectral AI, Inc. (0001833498) (Issuer)

    5/20/26 4:01:10 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    $MDAI
    SEC Filings

    View All

    Spectral AI Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Spectral AI, Inc. (0001833498) (Filer)

    6/1/26 4:01:42 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Spectral AI Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Spectral AI, Inc. (0001833498) (Filer)

    5/26/26 4:00:52 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Spectral AI Inc.

    SCHEDULE 13G/A - Spectral AI, Inc. (0001833498) (Subject)

    5/8/26 3:14:54 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    $MDAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Spectral AI Announces Voting Results of Annual Meeting of Stockholders

    DALLAS, June 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced results from its 2026 Annual Meeting of Stockholders, held on May 29, 2026. The Company also provided an overview of its accomplishments to date and targeted milestones for 2026 following the receipt of De Novo Classification for its DeepView® System from the U.S. Food and Drug Administration ("FDA"). 2026 Annual Meeting of Stockholders A total of 17,267,570 shares representing 54.3% of the Company's total shares outstanding were re

    6/1/26 8:00:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication

    DALLAS, May 26, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that the U.S. Food and Drug Administration (FDA) granted De Novo Classification for its DeepView® System. With this classification, Spectral AI is authorized to commence commercial distribution activities in the United States. The DeepView System is intended for use in burn care in various settings, including burn centers, trauma centers, and emergency departments. "We are pleased that the FDA has recognized our novel technology. I a

    5/26/26 7:00:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities

    AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: For decades, reliably identifying drug and alcohol impairment has been a persistent problem across industries, from traffic enforcement and occupational safety to clinical medicine and public health. Conventional tools such as breathalyzers, blood draws and urine tests are hampered by their intrusiveness, slow turnaround times or inability to capture real-time impairment, especially when multiple substances are involved. As substance-use patterns shift and the broader societal costs of intoxication continue to mount, the pressure to develop faster, less invasive, and more scalable detection methods is intensifyi

    5/13/26 8:30:00 AM ET
    $CAI
    $MDAI
    $NNOX
    Medical Specialities
    Health Care
    Medical/Dental Instruments
    Medical Electronics

    $MDAI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Dimaio John Michael bought $10,320 worth of shares (6,000 units at $1.72), increasing direct ownership by 0.40% to 2,491,908 units (SEC Form 4)

    4 - Spectral AI, Inc. (0001833498) (Issuer)

    5/14/24 11:17:43 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    $MDAI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on Spectral AI with a new price target

    BTIG Research initiated coverage of Spectral AI with a rating of Buy and set a new price target of $4.00

    1/23/24 7:24:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    $MDAI
    Leadership Updates

    Live Leadership Updates

    View All

    Spectral AI Announces Voting Results of Annual Meeting of Stockholders

    DALLAS, June 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced results from its 2026 Annual Meeting of Stockholders, held on May 29, 2026. The Company also provided an overview of its accomplishments to date and targeted milestones for 2026 following the receipt of De Novo Classification for its DeepView® System from the U.S. Food and Drug Administration ("FDA"). 2026 Annual Meeting of Stockholders A total of 17,267,570 shares representing 54.3% of the Company's total shares outstanding were re

    6/1/26 8:00:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Spectral AI Names David McGuire, CPA, as Chief Financial Officer

    DALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of David McGuire as the Company's Chief Financial Officer, effective May 4, 2026. "David's appointment as CFO is another important step in strengthening Spectral AI's financial leadership and strategic readiness as we prepare for commercialization of the DeepView® System," said Vincent S. Capone, Spectral AI's Chief Executive Officer. "David is a seasoned public company executive with experience in global markets, fin

    4/8/26 8:30:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Spectral AI Names Vincent S. Capone as Chief Executive Officer

    DALLAS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that the Company's Board of Directors has appointed Vincent S. Capone as Chief Executive Officer of the Company, effective February 9, 2026. The appointment of Mr. Capone, who currently serves as the Company's Chief Financial Officer and General Counsel, comes as Spectral AI transitions towards commercialization of its proprietary, non-invasive, AI-driven burn wound assessment device – the DeepView® System. "Vince brings a unique set

    2/10/26 8:30:00 AM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    $MDAI
    Financials

    Live finance-specific insights

    View All

    Spectral AI Announces 2026 First Quarter Financial Results

    Development Work for DeepView® Systems Continues with Support of Recently Awarded $31.7 Million of Funding from BARDA Reiterates Annual Revenues Guidance DALLAS, May 12, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the first quarter ended March 31, 2026. "Our results for the 2026 first quarter reflected the progress we have made in developing our DeepView® System for burn indication under the base phase of our Project BioShield Contract with BARDA," said Vincent Capone, Chief

    5/12/26 4:10:00 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call

    DALLAS, April 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the first quarter ended March 31, 2026 on Tuesday, May 12, 2026 after the close of the Nasdaq stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time on the same day to discuss its financial results. Investors interested in participating in the live call can dial into the conference call as follows: 833-890-6620 – U.S.412-564-3789 – International In addit

    4/28/26 4:15:00 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026

    Overview Full Year Research & Development Revenue of $19.7 Million; Q4 2025 Revenue of $3.8 MillionCash Rose to $15.4 Million at December 31, 2025 DALLAS, March 24, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence ("AI") company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the fourth quarter ("Q4 2025") and full year ("FY 2025") ended December 31, 2025 and provided an update on its ongoing activities related to the commercialization of its proprietary, AI-driven DeepView® System for burn indication. "2025 was a pivotal year fo

    3/24/26 4:25:00 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    $MDAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Spectral AI Inc.

    SC 13G/A - Spectral AI, Inc. (0001833498) (Subject)

    11/14/24 4:09:49 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Spectral AI Inc. (Amendment)

    SC 13G/A - Spectral AI, Inc. (0001833498) (Subject)

    4/19/24 6:49:51 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Spectral AI Inc. (Amendment)

    SC 13D/A - Spectral AI, Inc. (0001833498) (Subject)

    2/27/24 2:07:28 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care